AIDS Vaccine Candidate Successfully 'Primes' Immune System

The findings from the Burton, Nemazee and Schief labs could provide key information for the development of an effective AIDS vaccine.

Scientists Identify a Potential New Treatment for Osteoporosis

The approach from the Griffin lab could promote the development of new bone-forming cells.

New Close-Up View Reveals Key Part of Ebola Virus Life Cycle

The findings from the Ollmann Saphire lab add to the “blueprint” for developing effective treatments.

Findings Point to Drug Target for Huntington’s Disease

Research from the Subramaniam lab could help treat the neurological condition’s pathology and motor symptoms.

Team Sheds Light on Key Molecule Implicated in Diseases of the Brain

Research from the Chun lab and colleagues reveals a surprising link to marijuana receptor system.

Study Points to Unexplored Realm of Protein Biology, Drug Targets

Scientists in the Cravatt lab have devised a powerful set of chemical methods to study important molecular interactions that could become the basis of new drugs.

Scientists Awarded $3.5 Million to Expand Development of New Diabetes Therapies

The grant, led by Patrick Griffin, chair of the Department of Molecular Therapeutics, will fund deep dissection of the molecular mechanism of a new class of compounds developed at TSRI.